Table of Contents

1 Report Overview

• 1.1 Study Scope
• 1.2 Major Manufacturers Covered in This Report
• 1.3 Market Segment by Type
  • 1.3.1 Global Glucokinase Market Size Growth Rate by Type (2019-2025)
  • 1.3.2 LY-2608204
  • 1.3.3 Sinogliatin
  • 1.3.4 AM-9514
  • 1.3.5 TMG-123
  • 1.3.6 TTP-399
  • 1.3.7 Others
• 1.4 Market Segment by Application
  • 1.4.1 Global Glucokinase Market Share by Application (2019-2025)
  • 1.4.2 Metabolic Disorder
  • 1.4.3 Obesity
  • 1.4.4 Diabetes
  • 1.4.5 Others
• 1.5 Study Objectives
• 1.6 Years Considered

2 Global Growth Trends

• 2.1 Global Glucokinase Market Size
  • 2.1.1 Global Glucokinase Revenue 2014-2025
  • 2.1.2 Global Glucokinase Sales 2014-2025
• 2.2 Glucokinase Growth Rate by Regions
  • 2.2.1 Global Glucokinase Sales by Regions 2014-2019
  • 2.2.2 Global Glucokinase Revenue by Regions 2014-2019
• 2.3 Industry Trends
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers

3 Market Share by Manufacturers

• 3.1 Glucokinase Sales by Manufacturers
  • 3.1.1 Glucokinase Sales by Manufacturers 2014-2019
  • 3.1.2 Glucokinase Sales Market Share by Manufacturers 2014-2019
• 3.2 Revenue by Manufacturers
  • 3.2.1 Glucokinase Revenue by Manufacturers (2014-2019)
  • 3.2.2 Glucokinase Revenue Share by Manufacturers (2014-2019)
  • 3.2.3 Global Glucokinase Market Concentration Ratio (CR5 and HHI)
• 3.3 Glucokinase Price by Manufacturers
• 3.4 Key Manufacturers Glucokinase Plants/Factories Distribution and Area Served
• 3.5 Date of Key Manufacturers Enter into Glucokinase Market
• 3.6 Key Manufacturers Glucokinase Product Offered
• 3.7 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

• 4.1 Sales and Revenue for Each Type
  • 4.1.1 LY-2608204 Sales and Revenue (2014-2019)
  • 4.1.2 Sinogliatin Sales and Revenue (2014-2019)
  • 4.1.3 AM-9514 Sales and Revenue (2014-2019)
  • 4.1.4 TMG-123 Sales and Revenue (2014-2019)
  • 4.1.5 TTP-399 Sales and Revenue (2014-2019)
  • 4.1.6 Others Sales and Revenue (2014-2019)
• 4.2 Global Glucokinase Sales Market Share by Type
• 4.3 Global Glucokinase Revenue Market Share by Type
• 4.4 Glucokinase Price by Type

5 Market Size by Application

• 5.1 Overview
• 5.2 Global Glucokinase Sales by Application

6 United States

• 6.1 United States Glucokinase Breakdown Data by Company
• 6.2 United States Glucokinase Breakdown Data by Type
• 6.3 United States Glucokinase Breakdown Data by Application

7 European Union

• 7.1 European Union Glucokinase Breakdown Data by Company
• 7.2 European Union Glucokinase Breakdown Data by Type
• 7.3 European Union Glucokinase Breakdown Data by Application

8 China

• 8.1 China Glucokinase Breakdown Data by Company
• 8.2 China Glucokinase Breakdown Data by Type
• 8.3 China Glucokinase Breakdown Data by Application

9 Rest of World

• 9.1 Rest of World Glucokinase Breakdown Data by Company
• 9.2 Rest of World Glucokinase Breakdown Data by Type
• 9.3 Rest of World Glucokinase Breakdown Data by Application
• 9.4 Rest of World Glucokinase Breakdown Data by Countries
  • 9.4.1 Rest of World Glucokinase Sales by Countries
  • 9.4.2 Rest of World Glucokinase Revenue by Countries
  • 9.4.3 Japan
  • 9.4.4 Korea
  • 9.4.5 India
  • 9.4.6 Southeast Asia

10 Company Profiles

• 10.1 Amgen Inc
  • 10.1.1 Amgen Inc Company Details
  • 10.1.2 Company Description and Business Overview
  • 10.1.3 Sales, Revenue and Market Share of Glucokinase
  • 10.1.4 Glucokinase Product Introduction
  • 10.1.5 Amgen Inc Recent Development
• 10.2 Eli Lilly and Co
  • 10.2.1 Eli Lilly and Co Company Details
  • 10.2.2 Company Description and Business Overview
  • 10.2.3 Sales, Revenue and Market Share of Glucokinase
  • 10.2.4 Glucokinase Product Introduction
  • 10.2.5 Eli Lilly and Co Recent Development
• 10.3 Ligand Pharmaceuticals Inc
  • 10.3.1 Ligand Pharmaceuticals Inc Company Details
  • 10.3.2 Company Description and Business Overview
  • 10.3.3 Sales, Revenue and Market Share of Glucokinase
  • 10.3.4 Glucokinase Product Introduction
  • 10.3.5 Ligand Pharmaceuticals Inc Recent Development
• 10.4 Merck & Co Inc
  • 10.4.1 Merck & Co Inc Company Details
  • 10.4.2 Company Description and Business Overview
  • 10.4.3 Sales, Revenue and Market Share of Glucokinase
  • 10.4.4 Glucokinase Product Introduction
  • 10.4.5 Merck & Co Inc Recent Development
• 10.5 Poxel SA
  • 10.5.1 Poxel SA Company Details
  • 10.5.2 Company Description and Business Overview
  • 10.5.3 Sales, Revenue and Market Share of Glucokinase
  • 10.5.4 Glucokinase Product Introduction
  • 10.5.5 Poxel SA Recent Development
• 10.6 Teijin Pharma Ltd
  • 10.6.1 Teijin Pharma Ltd Company Details
  • 10.6.2 Company Description and Business Overview
  • 10.6.3 Sales, Revenue and Market Share of Glucokinase
  • 10.6.4 Glucokinase Product Introduction
  • 10.6.5 Teijin Pharma Ltd Recent Development
• 10.7 vTv Therapeutics Inc
  • 10.7.1 vTv Therapeutics Inc Company Details
  • 10.7.2 Company Description and Business Overview
  • 10.7.3 Sales, Revenue and Market Share of Glucokinase
  • 10.7.4 Glucokinase Product Introduction
  • 10.7.5 vTv Therapeutics Inc Recent Development
• 10.8 Yuhan Corp
  • 10.8.1 Yuhan Corp Company Details
  • 10.8.2 Company Description and Business Overview
  • 10.8.3 Sales, Revenue and Market Share of Glucokinase
  • 10.8.4 Glucokinase Product Introduction
  • 10.8.5 Yuhan Corp Recent Development

11 Value Chain and Sales Channels Analysis

• 11.1 Value Chain Analysis
• 11.2 Sales Channels Analysis
  • 11.2.1 Glucokinase Sales Channels
  • 11.2.2 Glucokinase Distributors
• 11.3 Glucokinase Customers

12 Market Forecast

• 12.1 Global Glucokinase Sales and Revenue Forecast 2019-2025
• 12.2 Global Glucokinase Sales Forecast by Type
• 12.3 Global Glucokinase Sales Forecast by Application
• 12.4 Glucokinase Forecast by Regions
  • 12.4.1 Global Glucokinase Sales Forecast by Regions 2019-2025
  • 12.4.2 Global Glucokinase Revenue Forecast by Regions 2019-2025
• 12.5 United States Market Forecast
• 12.6 European Union Market Forecast
• 12.7 China Market Forecast
• 12.8 Rest of World
  • 12.8.1 Japan
  • 12.8.2 Korea
  • 12.8.3 India

13 Research Findings and Conclusion

14 Appendix

• 14.1 Research Methodology
  • 14.1.1 Methodology/Research Approach
    • 14.1.1.1 Research Programs/Design
    • 14.1.1.2 Market Size Estimation
    • 14.1.1.3 Market Breakdown and Data Triangulation
  • 14.1.2 Data Source
    • 14.1.2.1 Secondary Sources
    • 14.1.2.2 Primary Sources
• 14.2 Author Details

In 2019, the market size of Glucokinase is million US$ and it will reach million US$ in 2025, growing at a CAGR of from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Glucokinase.

This report studies the global market size of Glucokinase, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Glucokinase sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

In global market, the following companies are covered:
Amgen Inc
Eli Lilly and Co
Ligand Pharmaceuticals Inc
Merck & Co Inc
Poxel SA
Teijin Pharma Ltd
vTv Therapeutics Inc
Yuhan Corp

Market Segment by Product Type
LY-2608204
Sinogliatin
AM-9514
TMG-123
TTP-399
Others

Market Segment by Application
Metabolic Disorder
Obesity
Diabetes
Others

Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)

The study objectives are:
To analyze and research the Glucokinase status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Glucokinase manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

In this study, the years considered to estimate the market size of Glucokinase are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025